Author:
Gupta Nalini,Hermansen Paul,Desai Mina
Publisher
Springer International Publishing
Reference9 articles.
1. Benevolo, M., Vocaturo, A., Mottolese, M., et al. (2008). Clinical role of p16INK4a expression in liquid-based cervical cytology: Correlation with HPV testing and histologic diagnosis. American Journal of Clinical Pathology, 129, 606–612.
2. Boucher, J., Anku-Bertholet, C., Temmar, R., & Pelmus, M. (2007). Evaluation of p16INK4a, minichromosome maintainance protein 2. DNA topoisomerase II alpha, ProEx C, and p16INK4a/ProEx C in cervical squamous intraepithelial lesions. Human Pathology, 38, 1335–1344.
3. Dehn, D., Torkko, K. C., & Shroyer, K. R. (2007). Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma. Cancer Cytopathology, 111, 1–14.
4. Gupta, N., Srinivasan, R., & Rajwanshi, A. (2010). Functional biomarkers in cervical precancer: An overview. Diagnostic Cytopathology, 38, 618–623.
5. Jones, H. W., III. (2006). Staging and pre-treatment evaluation of women with cervical cancer. In J. A. Jordan, A. Singer, H. W. Jones III, & M. Shafi (Eds.), The cervix (2nd ed., pp. 522–530). Oxford/London: Blackwell. Chapter 36.